GCM
KMTS

Ghisallo Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Ghisallo Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Hold
75,000
– – 0.04% 257
2026
Q1 		$1.49M Sell
75,000
-101,992
-58% -$2.4M 0.04% 216
2025
Q4 		$4.69M Buy
176,992
+101,992
+136% +$2.63M 0.21% 98
2025
Q3 		$1.78M Hold
75,000
– – 0.06% 183
2025
Q2 		$1.24M Hold
75,000
– – 0.03% 163
2025
Q1 		$1.87M Buy
+75,000
New +$1.72M 0.16% 84

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ghisallo Capital Management's KMTS Position: Q2 2026 in Review

Ghisallo Capital Management held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 75,000 shares worth $1.91M. The position accounts for 0.04% of the portfolio, ranked #257.

Ghisallo Capital Management first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.69M in Q4 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Ghisallo Capital Management held 75,000 shares of Kestra Medical Technologies worth $1.91M as of Q2 2026.
  • Ghisallo Capital Management left its Kestra Medical Technologies share count unchanged in Q2 2026.
  • Kestra Medical Technologies made up 0.04% of Ghisallo Capital Management's portfolio in Q2 2026, its #257 holding.
  • Ghisallo Capital Management first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Ghisallo Capital Management's Kestra Medical Technologies position peaked at $4.69M in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.